BioVisioN receives research grant within BioChancePLUS program

08-Aug-2005

BioVisioN AG announced the receipt of approval of a research grant within the German BioChancePLUS program. The German Federal Ministry of education and Research (BMBF) will fund the Project on "Functional Peptidomics" that aims at the characterisation of proteases and protease inhibitors with 560,000 EUR. In the project BioVisioN will apply its patent-protected Peptidomics® technologies to analyse substrates and products of proteases in vivo. The inhibition of proteases is an important mode of action of therapies in fields like diabetes and thrombosis.

By investigating the action of several protease inhibitors in animal models, BioVisioN will discover biomarkers for drug efficacy and possible side effects that can be used in early and advanced stages of drug development thus allowing early selection of the optimal drug candidate and the proper selection of patients responding to the drug, speeding up drug development and contributing to cost reduction.

Other news from the department science

More news from our other portals

So close that even
molecules turn red...